Chemical
Browse
Active Pharmaceutical Ingredients
Bioactive chemicals
Agrochemicals
Search
Chemical Structure
Explore
Chemical Similarity
Transformation
Browse
Prodrugs
Drug Metabolites
Metabolite Datasets
Biochemical Action
Browse
Target Level (ChEMBL)
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Mechanism of action
Search
Mechanism of action
BLAST against human drug target
BLAST against selected species (UniProt)
Exposure
Browse
Monitoring data
Downloads
Web services
Bulk downloads
About
About EcoDrug+
Citing
Data Sources
Contact Us
Versions and log file
Display Options:
Molecule Type
Mechanism of Action
Route of Adminstration
Status
Therapeutic Indication
Number of compounds:
7959
TOLVAPTAN
(2009)
Small molecule
Vasopressin V2 receptor antagonist
ORAL
Approved
Cardiovascular Diseases; Heart Failure; Hyponatremia; Polycystic Kidney Diseases
TOLVAPTAN
×
Maximum Phase:
4
First Approval:
2009
UNII:
21G72T1950
Molecule Type:
Small molecule
Molecular Formula:
C26H25ClN2O3
Molecular Weight:
448.95
AlogP:
5.68
PSA:
69.64
HBD:
2.0
HBA:
#RotB:
3.0
Source:
VIGABATRIN
(2009)
Small molecule
Gamma-amino-N-butyrate transaminase inhibitor
ORAL
Approved
Epilepsy; Epilepsy, Complex Partial; Spasms, Infantile
VIGABATRIN
×
Maximum Phase:
4
First Approval:
2009
UNII:
GR120KRT6K
Molecule Type:
Small molecule
Molecular Formula:
C6H11NO2
Molecular Weight:
129.16
AlogP:
0.36
PSA:
63.32
HBD:
2.0
HBA:
#RotB:
4.0
Source:
BEPOTASTINE
(2009)
Small molecule
Unknown
Unknown
Approved
Unknown
BEPOTASTINE
×
Maximum Phase:
4
First Approval:
2009
UNII:
HYD2U48IAS
Molecule Type:
Small molecule
Molecular Formula:
C21H25ClN2O3
Molecular Weight:
388.9
AlogP:
4.17
PSA:
62.66
HBD:
1.0
HBA:
#RotB:
8.0
Source:
PRASUGREL
(2009)
Small molecule
Unknown
Unknown
Approved
Thrombosis
PRASUGREL
×
Maximum Phase:
4
First Approval:
2009
UNII:
34K66TBT99
Molecule Type:
Small molecule
Molecular Formula:
C20H20FNO3S
Molecular Weight:
373.45
AlogP:
3.89
PSA:
46.61
HBD:
0.0
HBA:
#RotB:
5.0
Source:
PITAVASTATIN CALCIUM
(2009)
Small molecule
HMG-CoA reductase inhibitor
ORAL
Approved
Dyslipidemias; Hyperlipidemias
PITAVASTATIN CALCIUM
×
Maximum Phase:
4
First Approval:
2009
UNII:
IYD54XEG3W
Molecule Type:
Small molecule
Molecular Formula:
C50H46CaF2N2O8
Molecular Weight:
881.0
AlogP:
4.52
PSA:
90.65
HBD:
3.0
HBA:
#RotB:
8.0
Source:
MILNACIPRAN
(2009)
Small molecule
Unknown
Unknown
Approved
Depressive Disorder
MILNACIPRAN
×
Maximum Phase:
4
First Approval:
2009
UNII:
G56VK1HF36
Molecule Type:
Small molecule
Molecular Formula:
C15H22N2O
Molecular Weight:
246.35
AlogP:
1.77
PSA:
46.33
HBD:
1.0
HBA:
#RotB:
5.0
Source:
FEBUXOSTAT
(2009)
Small molecule
Xanthine dehydrogenase inhibitor
Unknown
Approved
Gout; Hyperuricemia
FEBUXOSTAT
×
Maximum Phase:
4
First Approval:
2009
UNII:
101V0R1N2E
Molecule Type:
Small molecule
Molecular Formula:
C16H16N2O3S
Molecular Weight:
316.38
AlogP:
3.72
PSA:
83.21
HBD:
1.0
HBA:
#RotB:
5.0
Source:
PITAVASTATIN
(2009)
Small molecule
Unknown
Unknown
Approved
Cardiovascular Diseases
PITAVASTATIN
×
Maximum Phase:
4
First Approval:
2009
UNII:
M5681Q5F9P
Molecule Type:
Small molecule
Molecular Formula:
C25H24FNO4
Molecular Weight:
421.47
AlogP:
4.52
PSA:
90.65
HBD:
3.0
HBA:
#RotB:
8.0
Source:
BAZEDOXIFENE ACETATE
(2009)
Small molecule
Estrogen receptor modulator
Unknown
Approved
Osteoporosis, Postmenopausal
BAZEDOXIFENE ACETATE
×
Maximum Phase:
4
First Approval:
2009
UNII:
J70472UD3D
Molecule Type:
Small molecule
Molecular Formula:
C32H38N2O5
Molecular Weight:
530.67
AlogP:
6.33
PSA:
57.86
HBD:
2.0
HBA:
#RotB:
7.0
Source:
EVEROLIMUS
(2009)
Small molecule
FK506-binding protein 1A inhibitor
ORAL
Approved
Angiomyolipoma; Astrocytoma; Breast Neoplasms; Carcinoma, Renal Cell; Immune System Diseases; Neoplasms; Neuroendocrine Tumors; Tuberous Sclerosis
EVEROLIMUS
×
Maximum Phase:
4
First Approval:
2009
UNII:
9HW64Q8G6G
Molecule Type:
Small molecule
Molecular Formula:
C53H83NO14
Molecular Weight:
958.24
AlogP:
6.2
PSA:
204.66
HBD:
3.0
HBA:
#RotB:
9.0
Source:
OMACETAXINE MEPESUCCINATE
(2009)
Small molecule
Protein synthesis inhibitor
SUBCUTANEOUS
Approved
Neoplasms
OMACETAXINE MEPESUCCINATE
×
Maximum Phase:
4
First Approval:
2009
UNII:
6FG8041S5B
Molecule Type:
Small molecule
Molecular Formula:
C29H39NO9
Molecular Weight:
545.63
AlogP:
2.58
PSA:
123.99
HBD:
2.0
HBA:
#RotB:
9.0
Source:
TELAVANCIN HYDROCHLORIDE
(2009)
Small molecule
Cell outer membrane inhibitor
INTRAVENOUS
Approved
Infections; Pneumonia, Bacterial
TELAVANCIN HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
2009
UNII:
0701472ZG0
Molecule Type:
Small molecule
Molecular Formula:
C80H107Cl3N11O27P
Molecular Weight:
1792.12
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
BESIFLOXACIN HYDROCHLORIDE
(2009)
Small molecule
Bacterial DNA gyrase inhibitor
OPHTHALMIC
Approved
Conjunctivitis, Bacterial
BESIFLOXACIN HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
2009
UNII:
7506A6J57T
Molecule Type:
Small molecule
Molecular Formula:
C19H22Cl2FN3O3
Molecular Weight:
430.31
AlogP:
3.14
PSA:
88.56
HBD:
2.0
HBA:
#RotB:
3.0
Source:
BENZYL ALCOHOL
(2009)
Small molecule
Unknown
TOPICAL
Approved
Ectoparasitic Infestations; Lice Infestations; Otitis Externa; Pruritus
BENZYL ALCOHOL
×
Maximum Phase:
4
First Approval:
2009
UNII:
LKG8494WBH
Molecule Type:
Small molecule
Molecular Formula:
C7H8O
Molecular Weight:
108.14
AlogP:
1.18
PSA:
20.23
HBD:
1.0
HBA:
#RotB:
1.0
Source:
PRALATREXATE
(2009)
Small molecule
Dihydrofolate reductase inhibitor
INJECTION; INTRAVENOUS
Approved
Lymphoma, T-Cell; Lymphoma, T-Cell, Peripheral; Neoplasms
PRALATREXATE
×
Maximum Phase:
4
First Approval:
2009
UNII:
A8Q8I19Q20
Molecule Type:
Small molecule
Molecular Formula:
C23H23N7O5
Molecular Weight:
477.48
AlogP:
0.98
PSA:
207.3
HBD:
5.0
HBA:
#RotB:
10.0
Source:
ULIPRISTAL ACETATE
(2010)
Small molecule
Progesterone receptor modulator
ORAL
Approved
Unknown
ULIPRISTAL ACETATE
×
Maximum Phase:
4
First Approval:
2010
UNII:
YF7V70N02B
Molecule Type:
Small molecule
Molecular Formula:
C30H37NO4
Molecular Weight:
475.63
AlogP:
5.54
PSA:
63.68
HBD:
0.0
HBA:
#RotB:
4.0
Source:
DABIGATRAN ETEXILATE
(2010)
Small molecule
Unknown
ORAL
Approved
Thrombosis
DABIGATRAN ETEXILATE
×
Maximum Phase:
4
First Approval:
2010
UNII:
2E18WX195X
Molecule Type:
Small molecule
Molecular Formula:
C34H41N7O5
Molecular Weight:
627.75
AlogP:
5.6
PSA:
154.03
HBD:
2.0
HBA:
#RotB:
15.0
Source:
LURASIDONE HYDROCHLORIDE
(2010)
Small molecule
Dopamine D2 receptor antagonist
ORAL
Approved
Bipolar Disorder; Schizophrenia
LURASIDONE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
2010
UNII:
O0P4I5851I
Molecule Type:
Small molecule
Molecular Formula:
C28H37ClN4O2S
Molecular Weight:
529.15
AlogP:
4.26
PSA:
56.75
HBD:
0.0
HBA:
#RotB:
5.0
Source:
MACITENTAN
(2010)
Small molecule
Endothelin receptor, ET-A/ET-B antagonist
ORAL
Approved
Familial Primary Pulmonary Hypertension; Hypertension
MACITENTAN
×
Maximum Phase:
4
First Approval:
2010
UNII:
Z9K9Y9WMVL
Molecule Type:
Small molecule
Molecular Formula:
C19H20Br2N6O4S
Molecular Weight:
588.28
AlogP:
3.57
PSA:
128.22
HBD:
2.0
HBA:
#RotB:
11.0
Source:
DALFAMPRIDINE
(2010)
Small molecule
Voltage-gated potassium channel blocker
ORAL
Approved
Multiple Sclerosis
DALFAMPRIDINE
×
Maximum Phase:
4
First Approval:
2010
UNII:
BH3B64OKL9
Molecule Type:
Small molecule
Molecular Formula:
C5H6N2
Molecular Weight:
94.12
AlogP:
0.66
PSA:
38.91
HBD:
1.0
HBA:
#RotB:
0.0
Source:
CARGLUMIC ACID
(2010)
Small molecule
Carbamoyl-phosphate synthase [ammonia], mitochondrial positive allosteric modulator
ORAL
Approved
Hyperammonemia
CARGLUMIC ACID
×
Maximum Phase:
4
First Approval:
2010
UNII:
5L0HB4V1EW
Molecule Type:
Small molecule
Molecular Formula:
C6H10N2O5
Molecular Weight:
190.16
AlogP:
-1.03
PSA:
129.72
HBD:
4.0
HBA:
#RotB:
5.0
Source:
LEVOMEFOLIC ACID
(2010)
Small molecule
Unknown
Unknown
Approved
Unknown
LEVOMEFOLIC ACID
×
Maximum Phase:
4
First Approval:
2010
UNII:
8S95DH25XC
Molecule Type:
Small molecule
Molecular Formula:
C20H25N7O6
Molecular Weight:
459.46
AlogP:
-0.26
PSA:
202.77
HBD:
7.0
HBA:
#RotB:
9.0
Source:
FINGOLIMOD
(2010)
Small molecule
Unknown
ORAL
Approved
Immune System Diseases
FINGOLIMOD
×
Maximum Phase:
4
First Approval:
2010
UNII:
3QN8BYN5QF
Molecule Type:
Small molecule
Molecular Formula:
C19H33NO2
Molecular Weight:
307.48
AlogP:
3.2
PSA:
66.48
HBD:
3.0
HBA:
#RotB:
12.0
Source:
LEVOMEFOLATE CALCIUM
(2010)
Small molecule
Unknown
Unknown
Approved
Acne Vulgaris; Anemia, Iron-Deficiency
LEVOMEFOLATE CALCIUM
×
Maximum Phase:
4
First Approval:
2010
UNII:
A9R10K3F2F
Molecule Type:
Small molecule
Molecular Formula:
C20H23CaN7O6
Molecular Weight:
497.53
AlogP:
-0.26
PSA:
202.77
HBD:
7.0
HBA:
#RotB:
9.0
Source:
ERIBULIN MESYLATE
(2010)
Small molecule
Tubulin inhibitor
INTRAVENOUS
Approved
Breast Neoplasms
ERIBULIN MESYLATE
×
Maximum Phase:
4
First Approval:
2010
UNII:
AV9U0660CW
Molecule Type:
Small molecule
Molecular Formula:
C41H63NO14S
Molecular Weight:
826.01
AlogP:
3.44
PSA:
146.39
HBD:
2.0
HBA:
#RotB:
4.0
Source:
HEXAMINOLEVULINATE
(2010)
Small molecule
Unknown
Unknown
Approved
Unknown
HEXAMINOLEVULINATE
×
Maximum Phase:
4
First Approval:
2010
UNII:
G7H20TKI67
Molecule Type:
Small molecule
Molecular Formula:
C11H21NO3
Molecular Weight:
215.29
AlogP:
1.42
PSA:
69.39
HBD:
1.0
HBA:
#RotB:
9.0
Source:
DABIGATRAN ETEXILATE MESYLATE
(2010)
Small molecule
Thrombin inhibitor
Unknown
Approved
Atrial Fibrillation; Embolism; Stroke; Venous Thrombosis
DABIGATRAN ETEXILATE MESYLATE
×
Maximum Phase:
4
First Approval:
2010
UNII:
SC7NUW5IIT
Molecule Type:
Small molecule
Molecular Formula:
C35H45N7O8S
Molecular Weight:
723.85
AlogP:
5.6
PSA:
154.03
HBD:
2.0
HBA:
#RotB:
15.0
Source:
ESTRADIOL VALERATE
(2010)
Small molecule
Estrogen receptor alpha agonist
INJECTION
Approved
Atrophy; Hypogonadism; Menopause; Menorrhagia; Primary Ovarian Insufficiency
ESTRADIOL VALERATE
×
Maximum Phase:
4
First Approval:
2010
UNII:
OKG364O896
Molecule Type:
Small molecule
Molecular Formula:
C23H32O3
Molecular Weight:
356.51
AlogP:
5.35
PSA:
46.53
HBD:
1.0
HBA:
#RotB:
4.0
Source:
DIENOGEST
(2010)
Small molecule
Unknown
Unknown
Approved
Menorrhagia
DIENOGEST
×
Maximum Phase:
4
First Approval:
2010
UNII:
46M3EV8HHE
Molecule Type:
Small molecule
Molecular Formula:
C20H25NO2
Molecular Weight:
311.42
AlogP:
3.84
PSA:
61.09
HBD:
1.0
HBA:
#RotB:
1.0
Source:
LURASIDONE
(2010)
Small molecule
Unknown
Unknown
Approved
Psychotic Disorders
LURASIDONE
×
Maximum Phase:
4
First Approval:
2010
UNII:
22IC88528T
Molecule Type:
Small molecule
Molecular Formula:
C28H36N4O2S
Molecular Weight:
492.69
AlogP:
4.26
PSA:
56.75
HBD:
0.0
HBA:
#RotB:
5.0
Source:
POTASSIUM SULFATE
(2010)
Small molecule
Unknown
Unknown
Approved
Unknown
POTASSIUM SULFATE
×
Maximum Phase:
4
First Approval:
2010
UNII:
1K573LC5TV
Molecule Type:
Small molecule
Molecular Formula:
K2O4S
Molecular Weight:
174.26
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
CEFTAROLINE FOSAMIL ACETATE
(2010)
Small molecule
Bacterial penicillin-binding protein inhibitor
Unknown
Approved
Kidney Failure, Chronic; Pneumonia, Bacterial
CEFTAROLINE FOSAMIL ACETATE
×
Maximum Phase:
4
First Approval:
2010
UNII:
P9VXV1408Y
Molecule Type:
Small molecule
Molecular Formula:
C24H27N8O11PS4
Molecular Weight:
762.77
AlogP:
-0.11
PSA:
223.24
HBD:
4.0
HBA:
#RotB:
11.0
Source:
CEFTAROLINE FOSAMIL
(2010)
Small molecule
Unknown
INTRAVENOUS
Approved
Bacterial Infections
CEFTAROLINE FOSAMIL
×
Maximum Phase:
4
First Approval:
2010
UNII:
7P6FQA5D21
Molecule Type:
Small molecule
Molecular Formula:
C22H21N8O8PS4
Molecular Weight:
684.7
AlogP:
-0.11
PSA:
223.24
HBD:
4.0
HBA:
#RotB:
11.0
Source:
CABAZITAXEL
(2010)
Small molecule
Tubulin inhibitor
INJECTION; INTRAVENOUS; IV (INFUSION)
Approved
Neoplasms; Prostatic Neoplasms
CABAZITAXEL
×
Maximum Phase:
4
First Approval:
2010
UNII:
51F690397J
Molecule Type:
Small molecule
Molecular Formula:
C45H57NO14
Molecular Weight:
835.94
AlogP:
4.57
PSA:
202.45
HBD:
3.0
HBA:
#RotB:
10.0
Source:
BOSUTINIB
(2010)
Small molecule
Bcr/Abl fusion protein
Unknown
Approved
Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Neoplasms
BOSUTINIB
×
Maximum Phase:
4
First Approval:
2010
UNII:
5018V4AEZ0
Molecule Type:
Small molecule
Molecular Formula:
C26H29Cl2N5O3
Molecular Weight:
530.46
AlogP:
5.19
PSA:
82.88
HBD:
1.0
HBA:
#RotB:
9.0
Source:
FINGOLIMOD HYDROCHLORIDE
(2010)
Small molecule
Sphingosine 1-phosphate receptor agonist
ORAL
Approved
Multiple Sclerosis
FINGOLIMOD HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
2010
UNII:
G926EC510T
Molecule Type:
Small molecule
Molecular Formula:
C19H34ClNO2
Molecular Weight:
343.94
AlogP:
3.2
PSA:
66.48
HBD:
3.0
HBA:
#RotB:
12.0
Source:
1
2
…
59
60
61
62
63
64
65
…
221
222
Next »
Download Option
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA